insulin aspart (NovoLog, Fiasp, Merilog)
Jump to navigation
Jump to search
Introduction
Synthetic proinsulin with more rapid onset & shorter duration of action than regular insulin, similar to insulin lispro.
Dosage
Pharmacokinetics
Mechanism of action
- 1 lysine & 1 proline residue of insulin substituted with aspartate residue[2]
Notes
More general terms
Additional terms
- lisproinsulin (Humalog, Lispro, Admelog, HumaPenn Memoir, HumaPenn Luxura HD, Humalog U-200 KwikPen)
Component of
References
- ↑ Prescriber's Letter 8(2):supplement 2001
- ↑ Jump up to: 2.0 2.1 Prescriber's Letter 8(10):58 2001
- ↑ Monaco K FDA OKs First Rapid-Acting Insulin Biosimilar for Diabetes. Approval makes Merilog the third insulin biosimilar. MedPage Today February 14, 2025 https://www.medpagetoday.com/endocrinology/type1diabetes/114245